To test this hypothesis, we first analyzed the integrated data from TCGA and found that TGFBR3 was expressed at low levels in high‐grade tumor tissues and that high levels of TGFBR3 were associated with favorable prognosis (Fig. 6A). This evidence concerns the gene TGFBR3 and neoplasm.